NCT03293485 - Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

September 14, 2018

Study Completion Date

September 14, 2018

Conditions

Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection

Interventions

DRUG

Imipenem+Cilastatin/Relebactam

Imipenem+Cilastatin/Relebactam 200/100 mg to 500/250 mg, depending on renal function, 30-minute IV infusion once every 6 hours

Trial Locations (29)

454-8502

Nagoya Ekisaikai Hospital ( Site 1724), Nagoya

471-8513

Toyota Memorial Hospital ( Site 1708), Toyota

807-0051

Medical Corporation Chiyukai Fukuoka Shin Mizumaki Hospital ( Site 1710), Onga-gun

824-0026

Shin Yukuhashi Hospital ( Site 1722), Yukuhashi

720-8520

National Hospital Organization Fukuyama Medical Center ( Site 1706), Fukuyama

721-8511

Fukuyama City Hospital ( Site 1721), Fukuyama

062-0931

KKR Sapporo Medical Center ( Site 1728), Sapporo

655-0031

Sano Hospital ( Site 1701), Kobe

311-3193

National Hospital Organization Mito Medical Center ( Site 1729), Higashiibaraki-gun

306-0041

Medical Corporation Tokushukai Koga General Hospital ( Site 1712), Koga

920-8530

Ishikawa Prefectural Central Hospital ( Site 1707), Kanazawa

920-8650

National Hospital Organization Kanazawa Medical Center ( Site 1716), Kanazawa

899-5431

Kawahara Clinic ( Site 1719), Aira

245-8575

National Hospital Organization Yokohama Medical Center ( Site 1702), Yokohama

514-1101

National Hospital Organization Mie Chuo Medical Center ( Site 1727), Tsu

981-8563

Japan Labour Health And Safety Organization Tohoku Rosai Hospital ( Site 1714), Sendai

983-8520

National Hospital Organization Sendai Medical Center ( Site 1723), Sendai

392-8510

Suwa Red Cross Hospital ( Site 1705), Suwa

856-8562

National Hospital Organization Nagasaki Medical Center ( Site 1718), Ōmura

586-8521

National Hospital Organization Osaka Minami Medical Center ( Site 1715), Kawachi-Nagano

329-1193

National Hospital Organization Utsunomiya National Hospital ( Site 1711), Utsunomiya

646-8558

National Hospital Organization Minami Wakayama Medical Center ( Site 1725), Tanabe

400-8506

Yamanashi Prefectural Central Hospital ( Site 1703), Kofu

918-8503

Fukuiken Saiseikai Hospital ( Site 1704), Fukui

811-0213

Medical Corporation Chiyukai Fukuoka Wajiro Hospital ( Site 1709), Fukuoka

890-0073

Medical Corporation Shingenkai Kawahara Urological Clinic ( Site 1726), Kagoshima

891-0105

Medical Corporation Seifukai Yagi Clinic ( Site 1720), Kagoshima

860-0008

National Hospital Organization Kumamoto Medical Center ( Site 1713), Kumamoto

870-0263

National Hospital Organization Oita Medical Center ( Site 1717), Ōita

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY